US FDA approves Provenge® for the treatment of advanced prostate cancer

被引：0

|

作者：

不详

机构：

来源：

EXPERT REVIEW OF ANTICANCER THERAPY | 2010年 / 10卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：793 / 793

页数：1

相关论文

共 50 条

[1] US FDA approves Provenge® for the treatment of advanced prostate cancer
不详
EXPERT REVIEW OF VACCINES, 2010, 9 (06) : 548 - 548
[2] US FDA approves Provenge® for the treatment of advanced prostate cancer
不详
FUTURE ONCOLOGY, 2010, 6 (06) : 882 - 882
[3] US FDA approves Jevtana® injection for advanced prostate cancer
不详
FUTURE ONCOLOGY, 2010, 6 (08) : 1208 - 1208
[4] US FDA approves Jevtana® injection for advanced prostate cancer
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (08) : 1169 - 1169
[5] FDA approves new combined treatment for advanced prostate cancer
不详
CANCER, 2023, 129 (24) : 3841 - 3842
[6] FDA approves prostate cancer treatment that inhibits testosterone synthesis
Thompson, Cheryl A.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2011, 68 (11) : 960 - 960
[7] FDA approves prostate cancer "vaccine"
Tanne, Janice Hopkins
BRITISH MEDICAL JOURNAL, 2010, 340
[8] US FDA approves regorafenib as a new treatment for metastatic colorectal cancer
不详
COLORECTAL CANCER, 2012, 1 (06) : 456 - 456
[9] US FDA APPROVES DOXEPIN FOR THE TREATMENT OF INSOMNIA
Naccari, Christopher
CNS SPECTRUMS, 2010, 15 (04) : 213 - 213
[10] FDA approves laserscope PDT laser for treatment of advanced lung cancer
不详
JOURNAL OF CLINICAL LASER MEDICINE & SURGERY, 1999, 17 (02): : 87 - 87

← 1 2 3 4 5 →